Similar Diseases
- DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS
- Aortic arch anomaly-facial dysmorphism-intellectual disability syndrome
- Onat syndrome
- Autosomal recessive syndrome of lymphedema, hydroceles, atrial septal defect, and characteristic facial changes
- Cleft Limb Heart Malformation Syndrome
- Stoll-Kieny-Dott syndrome
- Ectrodactyly cardiopathy dysmorphism
- Beemer Ertbruggen syndrome
- Ciuffo Syndrome
- Cardiospondylocarpofacial Syndrome
Made by DATEXIS (Data Science and Text-based Information Systems) at Beuth University of Applied Sciences Berlin
Deep Learning Technology: Sebastian Arnold, Betty van Aken, Paul Grundmann, Felix A. Gers and Alexander Löser. Learning Contextualized Document Representations for Healthcare Answer Retrieval. The Web Conference 2020 (WWW'20)
Funded by The Federal Ministry for Economic Affairs and Energy; Grant: 01MD19013D, Smart-MD Project, Digital Technologies
Results for Query ‹ DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS medication/1000 ›
Stroke – Prevention | Risk factors | Blood lipids
High cholesterol levels have been inconsistently associated with (ischemic) stroke. Statins have been shown to reduce the risk of stroke by about 15%. Since earlier meta-analyses of other lipid-lowering drugs did not show a decreased risk, statins might exert their effect through mechanisms other than their lipid-lowering effects.
Stroke – Prevention | Risk factors | Blood pressure
High blood pressure accounts for 35–50% of stroke risk. Blood pressure reduction of 10 mmHg systolic or 5 mmHg diastolic reduces the risk of stroke by ~40%. Lowering blood pressure has been conclusively shown to prevent both ischemic and hemorrhagic strokes. It is equally important in secondary prevention. Even patients older than 80 years and those with isolated systolic hypertension benefit from antihypertensive therapy. The available evidence does not show large differences in stroke prevention between antihypertensive drugs —therefore, other factors such as protection against other forms of cardiovascular disease and cost should be considered. The routine use of beta-blockers following a stroke or TIA has not been shown to result in benefits.